ArticleFrontiers in oncology2022

β-Hydroxyisovaleryl-Shikonin Exerts an Antitumor Effect on Pancreatic Cancer Through the PI3K/AKT Signaling Pathway.

Yu Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.